Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

MJ Taylor; ER Tiangga; R Ní Mhuircheartaigh; PJ Cowen

doi:10.1177/0269881111405359

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

MJ Taylor, ER Tiangga, R Ní Mhuircheartaigh, PJ Cowen

Research output: Contribution to journal › Article › peer-review

60 Citations (Scopus)

324 Downloads (Pure)

Abstract

Ketamine is a N-methyl-D-aspartic acid (NMDA) antagonist that has been associated with temporary clinical improvement in patients with depression. Studies using magnetic resonance spectroscopy (MRS) have shown that major depression is associated with decreased levels of glutamate and glutamine (Glx) in the anterior cingulate cortex, which normalize with clinical recovery. The present study aimed to test whether a ketamine infusion would increase cortical Glx levels in healthy volunteers. Healthy volunteers received an intravenous infusion of ketamine (0.5 mg kg−1, n = 8) or saline (n = 9) over 40 minutes. MRS measurements were obtained at baseline, during, and at the end of the infusion. The infusion of ketamine had significant effects on mental state but there was no effect of ketamine on the levels of Glx (F 3,39 = 1.70, p = 0.18) or glutamate (F 3,39 = 48, p = 0.70). This study suggests that the gradual infusion of low-dose ketamine in antidepressant doses not cause changes in cortical glutamate or glutamine in healthy volunteers that are visible by proton MRS.

Original language	English
Pages (from-to)	733-737
Number of pages	5
Journal	Journal of Psychopharmacology
Volume	26
Issue number	5
Early online date	26 May 2011
DOIs	https://doi.org/10.1177/0269881111405359
Publication status	Published - May 2012

Access to Document

10.1177/0269881111405359

Taylor ketamine glutamate MRSFinal published version, 867 KB
2012 taylor ketamine mrs jpsychopharm
This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/)
Final published version, 905 KB

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546630/

Cite this

@article{b84f35671e834f2a88fab821081533ea,

title = "Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study",

abstract = "Ketamine is a N-methyl-D-aspartic acid (NMDA) antagonist that has been associated with temporary clinical improvement in patients with depression. Studies using magnetic resonance spectroscopy (MRS) have shown that major depression is associated with decreased levels of glutamate and glutamine (Glx) in the anterior cingulate cortex, which normalize with clinical recovery. The present study aimed to test whether a ketamine infusion would increase cortical Glx levels in healthy volunteers. Healthy volunteers received an intravenous infusion of ketamine (0.5 mg kg−1, n = 8) or saline (n = 9) over 40 minutes. MRS measurements were obtained at baseline, during, and at the end of the infusion. The infusion of ketamine had significant effects on mental state but there was no effect of ketamine on the levels of Glx (F 3,39 = 1.70, p = 0.18) or glutamate (F 3,39 = 48, p = 0.70). This study suggests that the gradual infusion of low-dose ketamine in antidepressant doses not cause changes in cortical glutamate or glutamine in healthy volunteers that are visible by proton MRS.",

author = "MJ Taylor and ER Tiangga and {N{\'i} Mhuircheartaigh}, R and PJ Cowen",

year = "2012",

month = may,

doi = "10.1177/0269881111405359",

language = "English",

volume = "26",

pages = "733--737",

journal = "Journal of Psychopharmacology",

issn = "0269-8811",

publisher = "SAGE Publications Ltd STM",

number = "5",

}

TY - JOUR

T1 - Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers

T2 - a proton magnetic resonance spectroscopy study

AU - Taylor, MJ

AU - Tiangga, ER

AU - Ní Mhuircheartaigh, R

AU - Cowen, PJ

PY - 2012/5

Y1 - 2012/5

N2 - Ketamine is a N-methyl-D-aspartic acid (NMDA) antagonist that has been associated with temporary clinical improvement in patients with depression. Studies using magnetic resonance spectroscopy (MRS) have shown that major depression is associated with decreased levels of glutamate and glutamine (Glx) in the anterior cingulate cortex, which normalize with clinical recovery. The present study aimed to test whether a ketamine infusion would increase cortical Glx levels in healthy volunteers. Healthy volunteers received an intravenous infusion of ketamine (0.5 mg kg−1, n = 8) or saline (n = 9) over 40 minutes. MRS measurements were obtained at baseline, during, and at the end of the infusion. The infusion of ketamine had significant effects on mental state but there was no effect of ketamine on the levels of Glx (F 3,39 = 1.70, p = 0.18) or glutamate (F 3,39 = 48, p = 0.70). This study suggests that the gradual infusion of low-dose ketamine in antidepressant doses not cause changes in cortical glutamate or glutamine in healthy volunteers that are visible by proton MRS.

AB - Ketamine is a N-methyl-D-aspartic acid (NMDA) antagonist that has been associated with temporary clinical improvement in patients with depression. Studies using magnetic resonance spectroscopy (MRS) have shown that major depression is associated with decreased levels of glutamate and glutamine (Glx) in the anterior cingulate cortex, which normalize with clinical recovery. The present study aimed to test whether a ketamine infusion would increase cortical Glx levels in healthy volunteers. Healthy volunteers received an intravenous infusion of ketamine (0.5 mg kg−1, n = 8) or saline (n = 9) over 40 minutes. MRS measurements were obtained at baseline, during, and at the end of the infusion. The infusion of ketamine had significant effects on mental state but there was no effect of ketamine on the levels of Glx (F 3,39 = 1.70, p = 0.18) or glutamate (F 3,39 = 48, p = 0.70). This study suggests that the gradual infusion of low-dose ketamine in antidepressant doses not cause changes in cortical glutamate or glutamine in healthy volunteers that are visible by proton MRS.

U2 - 10.1177/0269881111405359

DO - 10.1177/0269881111405359

M3 - Article

SN - 0269-8811

VL - 26

SP - 733

EP - 737

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

IS - 5

ER -

Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: a proton magnetic resonance spectroscopy study

Abstract

Access to Document

Fingerprint

Cite this